Caxton Corp as of Dec. 31, 2025
Portfolio Holdings for Caxton Corp
Caxton Corp holds 11 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Gold Tr Gold Shs (GLD) | 64.5 | $2.8M | 7.0k | 396.31 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 8.3 | $357k | 710.00 | 502.49 | |
| Spyre Therapeutics Com New (SYRE) | 6.8 | $292k | 8.9k | 32.76 | |
| Mind Medicine Mindmed Com New (MNMD) | 4.9 | $210k | 16k | 13.39 | |
| Kyverna Therapeutics (KYTX) | 4.1 | $177k | 19k | 9.40 | |
| Compass Therapeutics (CMPX) | 3.7 | $158k | 30k | 5.37 | |
| Lexeo Therapeutics (LXEO) | 3.2 | $139k | 14k | 9.93 | |
| X4 Pharmaceuticals Com New (XFOR) | 1.5 | $62k | 16k | 4.00 | |
| Inhibikase Therapeutics Com New (IKT) | 1.4 | $58k | 29k | 2.05 | |
| Sab Biotherapeutics Com New (SABS) | 0.9 | $39k | 11k | 3.74 | |
| Context Therapeutics (CNTX) | 0.6 | $27k | 18k | 1.47 |
